hormonal therapy

Given the low mortality from slow-growing, localized prostate cancers and the side effects of many treatments, deciding whether to opt for monitoring or treatment can be excruciatingly difficult.
When the federally-funded Women s Health Initiative (WHI) study was terminated prematurely, in 2002, it created a firestorm of both concern and controversy.